BMY
40
-5
NWS
69
5
HCP
54
2
ES
12
3
AAL
56
5
COP
36
2
AEP
45
5
MCO
67
3
GIS
47
13
WFC
58
8
MAR
57
3
FCX
44
4
M
40
3
KR
50
5
TGT
35
4
OI
23
3
CRM
65
6
THC
52
9
CTAS
36
8
HSIC
42
2
BMY
40
-5
NWS
69
5
HCP
54
2
ES
12
3
AAL
56
5
COP
36
2
AEP
45
5
MCO
67
3
GIS
47
13
WFC
58
8
MAR
57
3
FCX
44
4
M
40
3
KR
50
5
TGT
35
4
OI
23
3
CRM
65
6
THC
52
9
CTAS
36
8
HSIC
42
2
Financhill
Back

bluebird bio 10K Form

Sell
22

BLUE
bluebird bio

Last Price:
$8.23
Seasonality Move:
-8.48%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive BLUE News And Ratings

See the #1 stock for the next 7 days that we like better than BLUE

BLUE Financial Statistics

Sales & Book Value

Annual Sales: $29.5M
Cash Flow: $-69.2M
Price / Cash Flow: 0
Annual Sales: $-0.60
Price / Book: 2.42

Profitability

EPS (TTM): -35.80000
Net Income (TTM): $-292.8M
Gross Margin: $-4M
Return on Equity: -245.94%
Return on Assets: -50.94%

bluebird bio Earnings Forecast

Key bluebird bio Financial Ratios

  • The Gross Profit Margin over the past 17 years for BLUE is -13.66%.
  • The Selling, General & Administrative Expenses for BLUE have been equal to 561.11% of Gross Profit Margin.
  • The Research & Development expenses have been 568.37% of Revenue.
  • The Interest Expense is -7.72% of Operating Income.
  • The Net Earning history of BLUE is -718.42% of Total Revenues.
  • Per Share Earnings over the last 18 years have been positive in 9 years.

bluebird bio Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: BLUE
CUSIP: 09609G
Website: bluebirdbio.com

Debt

Debt-to-Equity Ratio: -12.2
Current Ratio: 0.51
Quick Ratio: 0.3

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

BLUE Technical Analysis vs Fundamental Analysis

Sell
22
bluebird bio (BLUE) is a Sell

Is bluebird bio a Buy or a Sell?

  • bluebird bio stock is rated a Sell
    The current bluebird bio [BLUE] share price is $8.43. The Score for BLUE is 22, which is 56% below its historic median score of 50, and infers higher risk than normal.